The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab

The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab

Abstract Background It is not well known to what extent effectiveness of treatment with immune checkpoint inhibitors in stage IV non‐small‐cell lung cancer (NSCLC) is influenced by weight loss and changes in body composition. Therefore, the goal of this study was to evaluate body composition changes...

Full description

Bibliographic Details
Main Authors: Juliette H.R.J. Degens, Anne‐Marie C. Dingemans, Anna C.H. Willemsen, Hester A. Gietema, Daan P. Hurkmans, Joachim G. Aerts, Lizza E.L. Hendriks, Annemie M.W.J. Schols
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Non‐small‐cell lung cancer
Metastatic
Immune checkpoint inhibitors
Body composition changes
Weight changes
Overall survival
Online Access:https://doi.org/10.1002/jcsm.12698

Internet

https://doi.org/10.1002/jcsm.12698

Similar Items